Skip to main content
Veterinary Medicines

OVUCRON 25 �g/ml

Authorised
  • Lecirelin acetate

Product identification

Medicine name:
OVUCRON 25 �g/ml
OVUCRON 0,025 mg/ml injekčný roztok pre hovädzí dobytok a králiky
Active substance:
  • Lecirelin acetate
Target species:
  • Cattle (cow)
  • Rabbit (female for reproduction)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Lecirelin acetate
    0.03
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle (cow)
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Rabbit (female for reproduction)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH01CA92
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Package description:
  • box containing 1 vial of 20 ml
  • box containing 1 vial of 10 ml
  • box containing 15 vials of 2 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Fatro S.p.A.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 96/020/DC/17-S
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0269/001
Concerned member states:
  • Czechia
  • Slovakia

Documents

Summary of Product Characteristics

English (PDF)
Published on: 22/12/2023
Download

eu-PUAR-esv0269001-dcp-ovucron-0-025-mg-ml-en.pdf

English (PDF)
Published on: 22/12/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."